By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Evotec said today that it will use its high-throughput compound screening and assay development technologies to identify small molecule modulators for a target selected by Stockholm-based Active Biotech.
Registering provides access to this and other free content.
Already have an account?Login Now.
At her blog, Sally Rockey dives into National Institutes of Health funding data.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
Researchers report that what scents someone picks up can reflect their complement of immune genes.
The New York Times examines ethics and China's push to lead biomedical research.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.